During the past decade, Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin" are "Coronavirus" (2 trials). Many other conditions were trialed in "Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin" in a lesser frequency.

Most popular intervention types in "Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin" are "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "2019-nCoV PCR" (1 trials), "Sequencing" (1 trials) and "Serology" (1 trials). Other intervention names were less common.

The vast majority of trials in "Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".